HealthCap
Investor profile
Investment firmVenture capital
Also recorded as: Health Cap
Deals
20
distinct rounds
Companies
14
backed
Active span
2005–2025
21 yrs
Total round €
€491M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Industrifonden3
- Capio2
- Expon Capital2
- Lundbeckfond Ventures2
- MassMutual Ventures (MMV)2
- Novartis Venture Fund2
- Novo Holdings2
- Swedbank Robur2
- Abingworth LLP1
- Access Biotechnology1
- Avoro Capital Advisors1
- BioMedPartners1
- Columbus Venture Partners1
- Crowberry Capital1
- Deep Track Capital1
- DVH Ventures1
- Earlybird Venture Capital1
- EQT Life Sciences1
- Fåhraeus Startup and Growth1
- Fidelity1
- Finnish Inventure1
- Forbion1
- Fountain Healthcare Partners1
- GIMV1
- Inbox Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemab Therapeutics | Denmark | 1 | €127M |
| Precirix | Belgium | 1 | €80M |
| BONESUPPORT | Sweden | 3 | €55M |
| Vivet Therapeutics | France | 1 | €38M |
| OxThera | Sweden | 2 | €35M |
| GenSight Biologics | France | 1 | €33M |
| Doctrin | Sweden | 3 | €31M |
| Priothera Limited | Ireland | 1 | €30M |
| Ariceum Therapeutics | Germany | 1 | €25M |
| HelloBetter | Germany | 2 | €16M |
| Positrigo | Switzerland | 1 | €7.5M |
| Oncorena | Sweden | 1 | €6.4M |
| Oncos Therapeutics | Finland | 1 | €5.0M |
| Elsa Science | Sweden | 1 | €3.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Precirix | Series B | €80M | 2022-03 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |
| BONESUPPORT | Growth/Late | €34M | 2016-09 |
| GenSight Biologics | Series B | €33M | 2015-06 |
| Priothera Limited | Series A | €30M | 2020-10 |
| Ariceum Therapeutics | Series A | €25M | 2022-06 |
| OxThera | Other | €18M | 2005-06 |
| OxThera | Other | €17M | 2007-05 |
| BONESUPPORT | Growth/Late | €13M | 2011-05 |